 |
Eli Lilly and Company
LLY
|
$ 1 160.95
|
1.04 T
|
$ 2.37 B
|
72.0
|
17.4
|
$ 13.7
|
 |
 |
Akari Therapeutics, Plc
AKTX
|
$ 14.82
|
998 B
|
$ -30.7 M
|
-45.1
|
∙ |
$ -0.1
|
 |
 |
Johnson & Johnson
JNJ
|
$ 238.33
|
574 B
|
$ 9.42 B
|
20.2
|
5.8
|
$ 11.2
|
 |
 |
AbbVie
ABBV
|
$ 224.77
|
398 B
|
$ 15.3 B
|
116.5
|
6.0
|
$ 1.7
|
 |
 |
Merck & Co.
MRK
|
$ 120.76
|
302 B
|
$ 2.86 B
|
15.4
|
4.3
|
$ 7.3
|
 |
 |
Novartis AG
NVS
|
$ 153.92
|
227 B
|
$ 10.7 B
|
25.0
|
∙ |
$ 5.8
|
 |
 |
Amgen
AMGN
|
$ 354.06
|
190 B
|
$ 12.4 B
|
24.9
|
6.7
|
$ 13.2
|
 |
 |
Gilead Sciences
GILD
|
$ 125.87
|
157 B
|
$ 11 B
|
20.0
|
5.9
|
$ 6.7
|
 |
 |
Pfizer
PFE
|
$ 26.17
|
149 B
|
$ 6.52 B
|
12.5
|
2.5
|
$ 2.1
|
 |
 |
Bristol-Myers Squibb Company
BMY
|
$ 56.9
|
116 B
|
$ 11 B
|
17.4
|
2.4
|
$ 3.3
|
 |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 445.04
|
114 B
|
$ 4.32 B
|
28.6
|
9.2
|
$ 14.8
|
 |
 |
Regeneron Pharmaceuticals
REGN
|
$ 611.48
|
64 B
|
$ 3.4 B
|
17.5
|
5.2
|
$ 40.2
|
 |
 |
argenx SE
ARGX
|
$ 898.94
|
55.1 B
|
$ 1.23 B
|
19.6
|
∙ |
$ 41.2
|
 |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 34.56
|
39.6 B
|
$ 3.49 B
|
31.5
|
2.5
|
$ 1.1
|
 |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 289.39
|
37.9 B
|
$ -361 M
|
-154.4
|
15.6
|
$ -2.0
|
 |
 |
Zoetis
ZTS
|
$ 81.4
|
36.1 B
|
$ 485 M
|
14.4
|
4.1
|
$ 6.1
|
 |
 |
Axon Enterprise
AXON
|
$ 446.2
|
34.8 B
|
$ 160 M
|
106.5
|
10.6
|
$ 3.7
|
 |
 |
Biogen
BIIB
|
$ 199.96
|
29.3 B
|
$ 2.03 B
|
17.5
|
2.8
|
$ 10.8
|
 |
 |
Revolution Medicines
RVMD
|
$ 149.23
|
28.4 B
|
$ -1.26 B
|
∙ |
1232.2
|
$ -6.3
|
 |
 |
United Therapeutics Corporation
UTHR
|
$ 545.4
|
24.2 B
|
$ 1.57 B
|
21.2
|
8.3
|
$ 28.1
|
 |
 |
Royalty Pharma plc
RPRX
|
$ 55.29
|
23.8 B
|
$ 1.36 B
|
∙ |
9.1
|
$ 2.0
|
 |
 |
Incyte Corporation
INCY
|
$ 107.83
|
21 B
|
$ 710 M
|
19.6
|
4.1
|
$ 5.0
|
 |
 |
Zai Lab Limited
ZLAB
|
$ 17.64
|
19.3 B
|
$ -217 M
|
-123.6
|
50.1
|
$ -0.2
|
 |
 |
Moderna
MRNA
|
$ 49.64
|
19.3 B
|
$ -2.09 B
|
-9.1
|
5.8
|
$ -5.1
|
 |
 |
Insmed Incorporated
INSM
|
$ 96.72
|
19.2 B
|
$ -1.07 B
|
-18.6
|
32.2
|
$ -5.6
|
 |
 |
Mesoblast Limited
MESO
|
$ 14.12
|
17.1 B
|
∙ |
-55.9
|
115.4
|
$ -0.2
|
 |
 |
Neurocrine Biosciences
NBIX
|
$ 162.71
|
16.2 B
|
$ 225 M
|
30.6
|
5.0
|
$ 4.4
|
 |
 |
Exelixis
EXEL
|
$ 53.5
|
14.5 B
|
$ 524 M
|
16.0
|
5.2
|
$ 2.8
|
 |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 236.17
|
14.4 B
|
$ 1.79 M
|
-48.4
|
3.1
|
$ -4.4
|
 |
 |
Longeveron
LGVN
|
$ 0.77
|
13.5 B
|
$ -21.9 M
|
-0.6
|
10842.7
|
$ -1.2
|
 |
 |
Legend Biotech Corporation
LEGN
|
$ 36.28
|
13.4 B
|
$ -1.02 B
|
-18.5
|
13.9
|
$ -1.5
|
 |
 |
BridgeBio Pharma
BBIO
|
$ 67.55
|
12.9 B
|
$ -483 M
|
-18.6
|
23.8
|
$ -3.6
|
 |
 |
Axsome Therapeutics
AXSM
|
$ 253.77
|
12.6 B
|
$ -197 M
|
-49.9
|
20.3
|
$ -4.5
|
 |
 |
Ionis Pharmaceuticals
IONS
|
$ 73.82
|
11.8 B
|
$ -517 M
|
-45.3
|
12.5
|
$ -1.7
|
 |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.92
|
11.3 B
|
$ -14.8 M
|
6.7
|
20.2
|
$ 0.2
|
 |
 |
BioMarin Pharmaceutical
BMRN
|
$ 55.54
|
10.7 B
|
$ 804 M
|
16.0
|
3.3
|
$ 3.3
|
 |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 474.28
|
10.6 B
|
$ -401 M
|
∙ |
12.8
|
$ -13.6
|
 |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 74.41
|
9.95 B
|
$ -201 M
|
-44.5
|
16.6
|
$ -1.8
|
 |
 |
Summit Therapeutics
SMMT
|
$ 13.08
|
9.78 B
|
$ -609 M
|
-12.5
|
6511.8
|
$ -1.4
|
 |
 |
Krystal Biotech
KRYS
|
$ 321.55
|
9.31 B
|
$ 145 M
|
45.5
|
22.5
|
$ 6.3
|
 |
 |
Hutchison China MediTech Limited
HCM
|
$ 10.68
|
9.17 B
|
$ -75.9 M
|
11.2
|
6.2
|
$ 1.1
|
 |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 83.25
|
8.65 B
|
$ -480 K
|
125.2
|
7.4
|
$ 0.4
|
 |
 |
BioLineRx Ltd.
BLRX
|
$ 3.47
|
8.55 B
|
$ -38.8 M
|
-26.3
|
25.4
|
$ -0.1
|
 |
 |
Bio-Techne Corporation
TECH
|
$ 54.02
|
8.51 B
|
$ 394 M
|
44.7
|
6.3
|
$ 1.1
|
 |
 |
Halozyme Therapeutics
HALO
|
$ 70.73
|
8.48 B
|
$ 759 M
|
13.1
|
6.0
|
$ 5.1
|
 |
 |
Alkermes plc
ALKS
|
$ 44.92
|
7.4 B
|
$ 207 M
|
43.2
|
4.1
|
$ 0.8
|
 |
 |
Kymera Therapeutics
KYMR
|
$ 82.96
|
7.01 B
|
$ -316 M
|
-23.4
|
174.4
|
$ -3.5
|
 |
 |
Protagonist Therapeutics
PTGX
|
$ 109.79
|
6.98 B
|
$ 148 M
|
-76.3
|
66.4
|
$ -1.3
|
 |
 |
TG Therapeutics
TGTX
|
$ 48.05
|
6.93 B
|
$ -2.71 M
|
13.8
|
9.6
|
$ 3.0
|
 |
 |
Vaxcyte
PCVX
|
$ 47.29
|
6.44 B
|
$ -810 M
|
-9.3
|
∙ |
$ -6.1
|
 |
 |
Amarin Corporation plc
AMRN
|
$ 14.9
|
6.18 B
|
$ -56.2 M
|
-90.6
|
29.8
|
$ -0.2
|
 |
 |
Liquidia Corporation
LQDA
|
$ 71.63
|
6.16 B
|
$ -8.21 M
|
-139.8
|
23.0
|
$ -0.4
|
 |
 |
Immunovant
IMVT
|
$ 32.88
|
6 B
|
$ 771 K
|
-13.4
|
∙ |
$ -2.7
|
 |
 |
PTC Therapeutics
PTCT
|
$ 74.71
|
5.94 B
|
$ 1.02 B
|
6.2
|
2.8
|
$ 10.4
|
 |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 87.66
|
5.7 B
|
$ -189 M
|
-28.8
|
31.1
|
$ -3.2
|
 |
 |
Praxis Precision Medicines
PRAX
|
$ 247.98
|
5.58 B
|
$ -260 M
|
-25.3
|
4814.1
|
$ -13.2
|
 |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 44.69
|
5.13 B
|
$ -276 M
|
-13.7
|
50.7
|
$ -3.4
|
 |
 |
Amneal Pharmaceuticals
AMRX
|
$ 16.34
|
5.12 B
|
$ 584 M
|
42.9
|
1.5
|
$ 0.3
|
 |
 |
Mirum Pharmaceuticals
MIRM
|
$ 99.54
|
5 B
|
$ -782 M
|
∙ |
10.4
|
$ -13.8
|
 |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 254.57
|
4.92 B
|
$ 33.6 M
|
65.9
|
15.6
|
$ 3.4
|
 |
 |
CRISPR Therapeutics AG
CRSP
|
$ 50.23
|
4.52 B
|
$ -601 M
|
-8.5
|
1450.2
|
$ -6.2
|
 |
 |
Inhibrx
INBX
|
$ 93.54
|
4.41 B
|
$ -204 M
|
-22.9
|
11532.0
|
$ -4.7
|
 |
 |
Xenon Pharmaceuticals
XENE
|
$ 52.19
|
4.14 B
|
$ -291 M
|
-13.3
|
257.6
|
$ -4.2
|
 |
 |
Catalyst Pharmaceuticals
CPRX
|
$ 31.37
|
3.84 B
|
$ 200 M
|
16.8
|
6.5
|
$ 1.8
|
 |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 51.58
|
3.83 B
|
$ 54 M
|
118.2
|
6.8
|
$ 0.5
|
 |
 |
Veracyte
VCYT
|
$ 47.42
|
3.73 B
|
$ 60.6 M
|
60.6
|
6.3
|
$ 0.7
|
 |
 |
Denali Therapeutics
DNLI
|
$ 21.02
|
3.63 B
|
$ -504 M
|
-6.7
|
9.7
|
$ -2.9
|
 |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 21.39
|
3.6 B
|
$ 84.4 M
|
30.1
|
3.4
|
$ 0.7
|
 |
 |
Viking Therapeutics
VKTX
|
$ 28.61
|
3.22 B
|
$ -201 M
|
-22.2
|
∙ |
$ -1.4
|
 |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 33.53
|
3.15 B
|
$ -370 M
|
-8.9
|
333.4
|
$ -4.9
|
 |
 |
Arcutis Biotherapeutics
ARQT
|
$ 24.59
|
3.13 B
|
$ -70.2 M
|
-67.1
|
8.7
|
$ -0.4
|
 |
 |
Beam Therapeutics
BEAM
|
$ 29.41
|
2.91 B
|
$ -451 M
|
-7.4
|
54.2
|
$ -4.2
|
 |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 18.73
|
2.84 B
|
$ -47.8 M
|
-31.3
|
7.6
|
$ -0.4
|
 |
 |
Tarsus Pharmaceuticals
TARS
|
$ 62.61
|
2.62 B
|
$ -68.3 M
|
-41.0
|
5.9
|
$ -1.6
|
 |
 |
Supernus Pharmaceuticals
SUPN
|
$ 45.55
|
2.57 B
|
$ -19.2 M
|
-75.7
|
3.9
|
$ -0.6
|
 |
 |
Cue Biopharma
CUE
|
$ 27.09
|
2.57 B
|
$ -33 M
|
-18.0
|
214.0
|
$ -1.4
|
 |
 |
IDEAYA Biosciences
IDYA
|
$ 28.84
|
2.55 B
|
$ -171 M
|
-19.7
|
11.3
|
$ -1.5
|
 |
 |
Arcus Biosciences
RCUS
|
$ 23.3
|
2.5 B
|
$ -348 M
|
-6.2
|
11.1
|
$ -4.2
|
 |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 23.98
|
2.36 B
|
$ -664 M
|
-4.2
|
7.1
|
$ -6.0
|
 |
 |
DBV Technologies S.A.
DBVT
|
$ 16.54
|
2.31 B
|
$ -83 M
|
-19.5
|
642.0
|
$ -1.0
|
 |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 15.85
|
2.13 B
|
$ 123 M
|
18.2
|
7.2
|
$ 0.8
|
 |
 |
Immunic
IMUX
|
$ 13.07
|
2.03 B
|
$ -113 M
|
-7.8
|
∙ |
$ -1.7
|
 |
 |
Relay Therapeutics
RLAY
|
$ 14.24
|
2.03 B
|
$ -351 M
|
-7.6
|
86.9
|
$ -1.7
|
 |
 |
Harmony Biosciences Holdings
HRMY
|
$ 35.2
|
2.02 B
|
$ 219 M
|
10.8
|
2.2
|
$ 2.9
|
 |
 |
Celldex Therapeutics
CLDX
|
$ 29.96
|
1.99 B
|
$ -217 M
|
-8.6
|
477.9
|
$ -3.8
|
 |
 |
ADMA Biologics
ADMA
|
$ 8.32
|
1.98 B
|
$ 195 M
|
17.1
|
5.0
|
$ 0.6
|
 |
 |
Vericel Corporation
VCEL
|
$ 38.57
|
1.94 B
|
$ -7.98 M
|
-135.1
|
7.0
|
$ -0.3
|
 |
 |
Trevi Therapeutics
TRVI
|
$ 13.46
|
1.81 B
|
$ -45.7 M
|
-41.9
|
∙ |
$ -0.4
|
 |
 |
Kodiak Sciences
KOD
|
$ 33.97
|
1.81 B
|
$ -222 M
|
-10.4
|
∙ |
$ -4.2
|
 |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 8.5
|
1.78 B
|
$ -722 M
|
-3.0
|
2.9
|
$ -3.0
|
 |
 |
Taysha Gene Therapies
TSHA
|
$ 5.58
|
1.78 B
|
$ -125 M
|
-18.4
|
310.5
|
$ -0.4
|
 |
 |
Stoke Therapeutics
STOK
|
$ 29.36
|
1.74 B
|
$ 6.84 M
|
298.1
|
10.3
|
$ 0.1
|
 |
 |
Avidity Biosciences
RNA
|
$ 12.43
|
1.71 B
|
$ -586 M
|
-3.2
|
87.9
|
$ -4.0
|
 |
 |
Agios Pharmaceuticals
AGIO
|
$ 28.72
|
1.66 B
|
$ -381 M
|
2.4
|
31.0
|
$ 11.5
|
 |
 |
Viridian Therapeutics
VRDN
|
$ 16.14
|
1.64 B
|
$ -338 M
|
-4.6
|
26.9
|
$ -4.0
|
 |
 |
Catalyst Biosciences
CBIO
|
$ 18.34
|
1.64 B
|
$ 3.56 M
|
-938.0
|
16.4
|
$ -0.0
|
 |
 |
ANI Pharmaceuticals
ANIP
|
$ 81.65
|
1.64 B
|
$ 205 M
|
22.9
|
1.8
|
$ 3.6
|
 |
 |
Ocular Therapeutix
OCUL
|
$ 8.7
|
1.63 B
|
$ -208 M
|
-6.3
|
36.7
|
$ -1.6
|
 |
 |
Immunome
IMNM
|
$ 18.36
|
1.6 B
|
$ -239 M
|
-10.6
|
162.3
|
$ -2.2
|
 |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 2.34
|
1.57 B
|
$ -3.46 M
|
-534.0
|
979.1
|
$ -0.0
|
 |
 |
AbCellera Biologics
ABCL
|
$ 5.27
|
1.57 B
|
$ -223 M
|
-8.8
|
40.6
|
$ -0.6
|
 |
 |
AnaptysBio
ANAB
|
$ 54.24
|
1.56 B
|
$ -148 M
|
-16.7
|
12.4
|
$ -3.9
|
 |
 |
Syndax Pharmaceuticals
SNDX
|
$ 17.91
|
1.55 B
|
$ -241 M
|
-6.7
|
10.1
|
$ -3.0
|
 |
 |
uniQure N.V.
QURE
|
$ 26.82
|
1.54 B
|
$ -201 M
|
-5.7
|
86.3
|
$ -3.7
|
 |
 |
Innoviva
INVA
|
$ 22.44
|
1.51 B
|
$ 189 M
|
5.5
|
3.8
|
$ 4.1
|
 |
 |
Sarepta Therapeutics
SRPT
|
$ 15.0
|
1.5 B
|
$ 92.2 M
|
∙ |
0.9
|
$ -1.2
|
 |
 |
Nurix Therapeutics
NRIX
|
$ 16.98
|
1.47 B
|
$ -235 M
|
-5.5
|
18.8
|
$ -3.0
|
 |
 |
Novavax
NVAX
|
$ 9.03
|
1.46 B
|
$ 75.1 M
|
3.6
|
1.4
|
$ 2.6
|
 |
 |
KalVista Pharmaceuticals
KALV
|
$ 27.0
|
1.45 B
|
$ -155 M
|
∙ |
11.8
|
$ -3.3
|
 |
 |
UroGen Pharma Ltd.
URGN
|
$ 29.5
|
1.42 B
|
$ -126 M
|
-8.4
|
10.3
|
$ -3.1
|
 |
 |
Precigen
PGEN
|
$ 4.53
|
1.42 B
|
$ -423 K
|
-3.1
|
29.8
|
$ -1.4
|
 |
 |
Ardelyx
ARDX
|
$ 5.79
|
1.4 B
|
$ -107 M
|
-16.6
|
5.0
|
$ -0.4
|
 |
 |
Intellia Therapeutics
NTLA
|
$ 12.35
|
1.34 B
|
$ -433 M
|
-3.8
|
23.9
|
$ -3.8
|
 |
 |
Zymeworks
ZYME
|
$ 22.97
|
1.18 B
|
$ -263 M
|
-5.4
|
95.8
|
$ -4.6
|
 |
 |
Vir Biotechnology
VIR
|
$ 8.52
|
1.18 B
|
$ -669 M
|
-2.2
|
200.7
|
$ -4.6
|
 |
 |
Savara
SVRA
|
$ 5.27
|
1.17 B
|
$ -129 M
|
-9.2
|
1421.0
|
$ -0.6
|
 |
 |
Capricor Therapeutics
CAPR
|
$ 25.04
|
1.16 B
|
$ -114 M
|
-13.6
|
81.4
|
$ -2.2
|
 |
 |
MannKind Corporation
MNKD
|
$ 3.75
|
1.15 B
|
$ 57.4 M
|
59.3
|
3.3
|
$ 0.1
|
 |
 |
Xeris Pharmaceuticals
XERS
|
$ 6.93
|
1.11 B
|
$ 22.1 M
|
-39.0
|
3.7
|
$ -0.2
|
 |
 |
Collegium Pharmaceutical
COLL
|
$ 34.34
|
1.09 B
|
$ 153 M
|
20.6
|
1.6
|
$ 1.9
|
 |
 |
Nektar Therapeutics
NKTR
|
$ 59.21
|
999 M
|
$ -149 M
|
-9.4
|
278.4
|
$ -6.9
|
 |
 |
Wave Life Sciences Ltd.
WVE
|
$ 5.81
|
980 M
|
$ -142 M
|
-6.8
|
16.0
|
$ -1.0
|
 |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 20.53
|
960 M
|
$ 163 M
|
14.0
|
1.6
|
$ 1.7
|
 |
 |
Burford Capital Limited
BUR
|
$ 4.25
|
931 M
|
$ -1.33 B
|
-0.7
|
-0.6
|
$ -7.0
|
 |
 |
Corvus Pharmaceuticals
CRVS
|
$ 11.6
|
916 M
|
$ -45.5 M
|
-91.2
|
∙ |
$ -0.2
|
 |
 |
Xencor
XNCR
|
$ 12.09
|
898 M
|
$ -192 M
|
-4.6
|
9.5
|
$ -2.9
|
 |
 |
Eton Pharmaceuticals
ETON
|
$ 32.11
|
864 M
|
$ 1.69 M
|
-176.2
|
9.7
|
$ -0.2
|
 |
 |
Olema Pharmaceuticals
OLMA
|
$ 9.75
|
848 M
|
$ -156 M
|
-7.4
|
∙ |
$ -1.9
|
 |
 |
Certara
CERT
|
$ 5.27
|
845 M
|
$ 64 M
|
-171.0
|
2.0
|
$ -0.0
|
 |
 |
SELLAS Life Sciences Group
SLS
|
$ 7.75
|
845 M
|
$ -41.8 M
|
-20.9
|
47.5
|
$ -0.2
|
 |
 |
Theravance Biopharma
TBPH
|
$ 16.49
|
830 M
|
$ -61.2 M
|
21.5
|
10.8
|
$ 0.8
|
 |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.29
|
822 M
|
$ 107 M
|
6.0
|
4.3
|
$ 0.7
|
 |
 |
Seres Therapeutics
MCRB
|
$ 6.32
|
809 M
|
$ -91.5 M
|
21.4
|
7.5
|
$ 0.4
|
 |
 |
Cullinan Management
CGEM
|
$ 12.98
|
782 M
|
$ -214 M
|
-4.6
|
46.8
|
$ -3.2
|
 |
 |
Kura Oncology
KURA
|
$ 8.86
|
777 M
|
$ -197 M
|
-3.1
|
12.4
|
$ -3.1
|
 |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.6
|
772 M
|
$ -161 M
|
-4.6
|
52.3
|
$ -2.2
|
 |
 |
Geron Corporation
GERN
|
$ 1.14
|
760 M
|
$ -112 M
|
-17.6
|
5.6
|
$ -0.1
|
 |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 5.21
|
752 M
|
$ -136 M
|
-7.1
|
3.2
|
$ -0.7
|
 |
 |
Phathom Pharmaceuticals
PHAT
|
$ 10.27
|
749 M
|
$ -296 M
|
-2.4
|
10.0
|
$ -5.2
|
 |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 11.37
|
735 M
|
$ -613 M
|
-0.7
|
0.9
|
$ -15.0
|
 |
 |
Annexon
ANNX
|
$ 4.7
|
729 M
|
$ -210 M
|
-4.2
|
∙ |
$ -1.3
|
 |
 |
Sana Biotechnology
SANA
|
$ 2.77
|
701 M
|
$ -226 M
|
-3.8
|
∙ |
$ -0.9
|
 |
 |
Replimune Group
REPL
|
$ 8.62
|
694 M
|
$ -309 M
|
-0.8
|
∙ |
$ -3.4
|
 |
 |
ORIC Pharmaceuticals
ORIC
|
$ 7.82
|
687 M
|
$ -112 M
|
-5.6
|
∙ |
$ -1.7
|
 |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.89
|
686 M
|
$ -103 M
|
-6.0
|
9.3
|
$ -0.3
|
 |
 |
Esperion Therapeutics
ESPR
|
$ 3.15
|
655 M
|
$ -118 M
|
-5.9
|
2.1
|
$ -0.5
|
 |
 |
Omeros Corporation
OMER
|
$ 10.18
|
647 M
|
$ -110 M
|
-20.5
|
10.2
|
$ -0.7
|
 |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.63
|
587 M
|
$ 116 M
|
9.9
|
1.9
|
$ 0.4
|
 |
 |
Rigel Pharmaceuticals
RIGL
|
$ 32.08
|
577 M
|
$ 117 M
|
4.7
|
1.8
|
$ 6.0
|
 |
 |
Aclaris Therapeutics
ACRS
|
$ 4.37
|
536 M
|
$ -75.4 M
|
-9.4
|
69.9
|
$ -0.5
|
 |
 |
XOMA Corporation
XOMA
|
$ 41.8
|
505 M
|
$ 11.7 M
|
29.0
|
10.0
|
$ 1.4
|
 |
 |
Arvinas
ARVN
|
$ 7.09
|
503 M
|
$ -105 M
|
-8.9
|
2.6
|
$ -1.1
|
 |
 |
Cerus Corporation
CERS
|
$ 2.59
|
494 M
|
$ -26.3 M
|
-25.9
|
3.9
|
$ -0.1
|
 |
 |
Benitec Biopharma
BNTC
|
$ 11.05
|
455 M
|
$ -50.1 M
|
-12.1
|
3752.0
|
$ -1.0
|
 |
 |
Aquestive Therapeutics
AQST
|
$ 4.21
|
450 M
|
$ -45.9 M
|
-7.0
|
9.6
|
$ -0.6
|
 |
 |
Prothena Corporation plc
PRTA
|
$ 8.26
|
445 M
|
$ -160 M
|
-3.0
|
9.3
|
$ -3.5
|
 |
 |
Monopar Therapeutics
MNPR
|
$ 59.1
|
438 M
|
$ -15.8 M
|
-36.5
|
∙ |
$ -1.7
|
 |
 |
Kamada Ltd.
KMDA
|
$ 7.44
|
429 M
|
$ 48.9 M
|
12.9
|
0.8
|
$ 0.6
|
 |
 |
Plus Therapeutics
PSTV
|
$ 5.42
|
422 M
|
$ -17.7 M
|
-2.3
|
83.8
|
$ -2.3
|
 |
 |
Tenax Therapeutics
TENX
|
$ 10.73
|
421 M
|
$ -16.9 M
|
-9.4
|
1270.5
|
$ -1.3
|
 |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.56
|
415 M
|
$ -249 M
|
-1.6
|
5.5
|
$ -1.0
|
 |
 |
Allogene Therapeutics
ALLO
|
$ 1.88
|
415 M
|
$ -267 M
|
-2.6
|
5354.7
|
$ -0.9
|
 |
 |
CytomX Therapeutics
CTMX
|
$ 2.98
|
411 M
|
$ 9.1 M
|
26.7
|
6.4
|
$ 0.2
|
 |
 |
Ocugen
OCGN
|
$ 1.22
|
381 M
|
$ -74.6 M
|
-6.0
|
81.1
|
$ -0.2
|
 |
 |
Keros Therapeutics
KROS
|
$ 10.05
|
374 M
|
$ 40 M
|
7.3
|
1.7
|
$ 1.5
|
 |
 |
Puma Biotechnology
PBYI
|
$ 7.23
|
362 M
|
$ 21.9 M
|
25.0
|
1.8
|
$ 0.3
|
 |
 |
Vanda Pharmaceuticals
VNDA
|
$ 6.1
|
359 M
|
$ -158 M
|
-3.0
|
1.8
|
$ -2.2
|
 |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.36
|
355 M
|
$ -198 M
|
-2.8
|
2.8
|
$ -1.9
|
 |
 |
REGENXBIO
RGNX
|
$ 6.28
|
324 M
|
$ -185 M
|
-1.5
|
2.2
|
$ -4.2
|
 |
 |
C4 Therapeutics
CCCC
|
$ 3.87
|
321 M
|
$ -118 M
|
-2.3
|
8.4
|
$ -1.4
|
 |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 4.11
|
316 M
|
$ -111 M
|
-3.8
|
25.4
|
$ -1.2
|
 |
 |
Greenwich LifeSciences
GLSI
|
$ 23.03
|
312 M
|
$ -14.2 M
|
-25.9
|
∙ |
$ -1.0
|
 |
 |
Cellectis S.A.
CLLS
|
$ 3.09
|
310 M
|
$ -119 M
|
-2.5
|
0.8
|
$ -1.6
|
 |
 |
SIGA Technologies
SIGA
|
$ 4.31
|
308 M
|
$ 2.15 M
|
13.5
|
3.5
|
$ 0.4
|
 |
 |
Cabaletta Bio
CABA
|
$ 3.01
|
302 M
|
$ -125 M
|
-1.6
|
∙ |
$ -2.3
|
 |
 |
Larimar Therapeutics
LRMR
|
$ 3.6
|
299 M
|
$ -86.4 M
|
-2.3
|
∙ |
$ -1.7
|
 |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.66
|
296 M
|
$ -226 M
|
-1.8
|
∙ |
$ -2.0
|
 |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.28
|
295 M
|
$ -37 M
|
-4.4
|
31.6
|
$ -0.3
|
 |
 |
Rezolute
RZLT
|
$ 3.86
|
293 M
|
$ -81.2 M
|
-4.2
|
∙ |
$ -0.8
|
 |
 |
Abeona Therapeutics
ABEO
|
$ 5.53
|
293 M
|
$ -87.1 M
|
4.0
|
21.6
|
$ 1.4
|
 |
 |
Shattuck Labs
STTK
|
$ 4.18
|
291 M
|
$ -67.8 M
|
-8.0
|
64.8
|
$ -0.8
|
 |
 |
Ovid Therapeutics
OVID
|
$ 2.21
|
288 M
|
$ -47.7 M
|
-7.0
|
55.7
|
$ -0.4
|
 |
 |
Bicycle Therapeutics plc
BCYC
|
$ 4.1
|
284 M
|
$ -260 M
|
-1.4
|
13.6
|
$ -3.5
|
 |
 |
Verastem
VSTM
|
$ 3.94
|
273 M
|
$ -136 M
|
-1.8
|
9.3
|
$ -3.1
|
 |
 |
Armata Pharmaceuticals
ARMP
|
$ 7.47
|
271 M
|
$ -30.1 M
|
-2.0
|
10310.6
|
$ -4.5
|
 |
 |
DiaMedica Therapeutics
DMAC
|
$ 5.46
|
257 M
|
$ -29.9 M
|
-9.1
|
612.6
|
$ -0.7
|
 |
 |
Foghorn Therapeutics
FHTX
|
$ 4.06
|
256 M
|
$ -81.2 M
|
-3.8
|
10.6
|
$ -1.1
|
 |
 |
MacroGenics
MGNX
|
$ 4.01
|
253 M
|
$ -160 M
|
-2.2
|
1.7
|
$ -1.5
|
 |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 3.52
|
253 M
|
$ -153 M
|
-2.2
|
7.9
|
$ -1.9
|
 |
 |
Fennec Pharmaceuticals
FENC
|
$ 8.85
|
253 M
|
$ -16.6 M
|
-57.8
|
5.7
|
$ -0.2
|
 |
 |
Assembly Biosciences
ASMB
|
$ 22.53
|
253 M
|
$ -51.4 M
|
-8.2
|
9.1
|
$ -3.8
|
 |
 |
Achieve Life Sciences
ACHV
|
$ 5.52
|
241 M
|
$ 317 K
|
-5.0
|
∙ |
$ -1.2
|
 |
 |
Fate Therapeutics
FATE
|
$ 1.97
|
234 M
|
$ -139 M
|
-1.9
|
38.5
|
$ -1.1
|
 |
 |
Akebia Therapeutics
AKBA
|
$ 0.9
|
231 M
|
$ 6.23 M
|
-8.4
|
1.3
|
$ -0.1
|
 |
 |
Altimmune
ALT
|
$ 2.59
|
228 M
|
$ -94.8 M
|
-3.3
|
13303.7
|
$ -0.9
|
 |
 |
Forte Biosciences
FBRX
|
$ 17.4
|
225 M
|
$ -49.7 M
|
-5.7
|
18.7
|
$ -4.6
|
 |
 |
Sutro Biopharma
STRO
|
$ 26.48
|
225 M
|
$ -190 M
|
-8.2
|
3.1
|
$ -4.7
|
 |
 |
Editas Medicine
EDIT
|
$ 2.44
|
217 M
|
$ -214 M
|
-1.4
|
14.5
|
$ -2.1
|
 |
 |
Anavex Life Sciences Corp.
AVXL
|
$ 2.5
|
213 M
|
$ -51.1 M
|
-6.9
|
∙ |
$ -0.5
|
 |
 |
Adagene
ADAG
|
$ 3.58
|
211 M
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Anika Therapeutics
ANIK
|
$ 14.72
|
211 M
|
$ -7.68 M
|
-13.0
|
2.0
|
$ -1.2
|
 |
 |
Codexis
CDXS
|
$ 2.41
|
210 M
|
$ -55.2 M
|
-3.5
|
4.8
|
$ -0.7
|
 |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 75.3
|
210 M
|
$ -6.16 M
|
-43.3
|
3.9
|
$ -1.7
|
 |
 |
BioAtla
BCAB
|
$ 3.56
|
209 M
|
$ -79.5 M
|
-0.8
|
418.7
|
$ -5.1
|
 |
 |
Nkarta
NKTX
|
$ 2.76
|
204 M
|
$ -113 M
|
-2.3
|
2068.8
|
$ -1.4
|
 |
 |
Voyager Therapeutics
VYGR
|
$ 3.46
|
203 M
|
$ 46 M
|
-1.9
|
8.4
|
$ -2.0
|
 |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 6.97
|
191 M
|
$ -70.8 M
|
-3.9
|
3.2
|
$ -2.3
|
 |
 |
Compugen Ltd.
CGEN
|
$ 2.04
|
191 M
|
$ -10.9 M
|
-71.5
|
2.4
|
$ -0.0
|
 |
 |
Galectin Therapeutics
GALT
|
$ 2.61
|
167 M
|
$ -31.8 M
|
-4.5
|
-355.6
|
$ -0.5
|
 |
 |
Coherus BioSciences
CHRS
|
$ 1.42
|
166 M
|
$ -170 M
|
1.3
|
5.5
|
$ 1.5
|
 |
 |
Inhibikase Therapeutics
IKT
|
$ 1.67
|
164 M
|
$ -56 M
|
-3.9
|
704.9
|
$ -0.5
|
 |
 |
X4 Pharmaceuticals
XFOR
|
$ 3.88
|
164 M
|
$ 7.85 M
|
-1.0
|
27.6
|
$ -4.3
|
 |
 |
Alector
ALEC
|
$ 1.57
|
162 M
|
$ -159 M
|
-1.9
|
15.8
|
$ -1.3
|
 |
 |
Equillium
EQ
|
$ 2.81
|
161 M
|
$ -21.3 M
|
-4.4
|
2.9
|
$ -0.5
|
 |
 |
Protalix BioTherapeutics
PLX
|
$ 2.05
|
161 M
|
$ 11 M
|
7.7
|
2.0
|
$ 0.2
|
 |
 |
Oramed Pharmaceuticals
ORMP
|
$ 3.8
|
157 M
|
$ -16.2 M
|
1.9
|
33.6
|
$ 2.2
|
 |
 |
Protara Therapeutics
TARA
|
$ 3.65
|
156 M
|
$ -55 M
|
-4.1
|
75.6
|
$ -1.3
|
 |
 |
Spero Therapeutics
SPRO
|
$ 2.7
|
151 M
|
$ -58.3 M
|
-4.5
|
5.3
|
$ -0.5
|
 |
 |
Milestone Pharmaceuticals
MIST
|
$ 1.27
|
135 M
|
$ -70 M
|
-2.1
|
767.8
|
$ -0.8
|
 |
 |
Atara Biotherapeutics
ATRA
|
$ 10.46
|
131 M
|
$ -1.43 M
|
3.1
|
1.0
|
$ 3.1
|
 |
 |
vTv Therapeutics
VTVT
|
$ 31.59
|
124 M
|
$ -1.62 M
|
∙ |
3.2
|
∙ |
 |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 1.13
|
121 M
|
$ -33.8 M
|
-5.2
|
∙ |
$ -0.3
|
 |
 |
Cardiff Oncology
CRDF
|
$ 1.59
|
106 M
|
$ -53.6 M
|
-2.3
|
295.7
|
$ -0.8
|
 |
 |
ADC Therapeutics SA
ADCT
|
$ 1.06
|
105 M
|
$ -239 M
|
-1.4
|
6.2
|
$ -2.8
|
 |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 7.78
|
104 M
|
$ -87.3 M
|
-1.9
|
72.1
|
$ -6.0
|
 |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.82
|
103 M
|
$ 1.79 M
|
5.4
|
2.2
|
$ 0.5
|
 |
 |
Aldeyra Therapeutics
ALDX
|
$ 1.71
|
103 M
|
$ -39.9 M
|
-3.3
|
∙ |
$ -0.5
|
 |
 |
Agenus
AGEN
|
$ 3.39
|
101 M
|
$ -75.8 M
|
3.3
|
0.8
|
$ 1.0
|
 |
 |
Seer
SEER
|
$ 1.7
|
93.5 M
|
$ -72.7 M
|
-1.3
|
7.4
|
$ -1.4
|
 |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 10.65
|
90.6 M
|
$ -117 M
|
-1.1
|
8.2
|
$ -13.2
|
 |
 |
ImmuCell Corporation
ICCC
|
$ 9.74
|
87.9 M
|
$ 6.25 M
|
20.2
|
2.4
|
$ 0.4
|
 |
 |
Champions Oncology
CSBR
|
$ 6.42
|
87.7 M
|
$ 5.92 M
|
18.1
|
1.3
|
$ 0.3
|
 |
 |
ALX Oncology Holdings
ALXO
|
$ 1.52
|
81.6 M
|
$ -99.2 M
|
-1.3
|
30.8
|
$ -1.6
|
 |
 |
Fortress Biotech
FBIO
|
$ 2.76
|
77 M
|
$ -72.9 M
|
0.6
|
1.0
|
$ 3.6
|
 |
 |
PolyPid Ltd.
PYPD
|
$ 4.57
|
74.7 M
|
$ -71.9 M
|
0.5
|
∙ |
$ 9.0
|
 |
 |
XBiotech
XBIT
|
$ 2.33
|
71 M
|
$ -36.2 M
|
-3.1
|
9.3
|
$ -0.8
|
 |
 |
Pliant Therapeutics
PLRX
|
$ 1.14
|
70 M
|
$ -153 M
|
-0.5
|
9.2
|
$ -2.4
|
 |
 |
Heron Therapeutics
HRTX
|
$ 0.41
|
68.3 M
|
$ -37 M
|
-6.9
|
1.1
|
$ -0.1
|
 |
 |
BeyondSpring
BYSI
|
$ 1.65
|
67.9 M
|
$ -54 M
|
-72.5
|
31.6
|
$ -0.0
|
 |
 |
Verrica Pharmaceuticals
VRCA
|
$ 6.03
|
64.2 M
|
$ -14.6 M
|
-12.8
|
2.1
|
$ -0.6
|
 |
 |
Lixte Biotechnology Holdings
LIXT
|
$ 7.25
|
63.7 M
|
$ -5.14 M
|
-4.6
|
∙ |
$ -1.1
|
 |
 |
MediciNova
MNOV
|
$ 1.28
|
62.8 M
|
$ -12.1 M
|
-5.8
|
47.5
|
$ -0.2
|
 |
 |
Rafael Holdings
RFL
|
$ 2.12
|
62.4 M
|
$ -22.8 M
|
-1.4
|
48.0
|
$ -0.9
|
 |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.09
|
57.3 M
|
$ -85.8 M
|
-1.0
|
∙ |
$ -1.5
|
 |
 |
Entera Bio Ltd.
ENTX
|
$ 1.16
|
53.6 M
|
$ -12 M
|
5.0
|
283.1
|
$ 0.3
|
 |
 |
Aligos Therapeutics
ALGS
|
$ 5.28
|
52.2 M
|
$ -92.1 M
|
-3.6
|
12.3
|
$ -1.7
|
 |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.12
|
52 M
|
$ -35.1 M
|
-1.9
|
∙ |
$ -0.7
|
 |
 |
Inovio Pharmaceuticals
INO
|
$ 1.1
|
51.6 M
|
$ -121 M
|
-0.6
|
38.1
|
$ -2.3
|
 |
 |
Lantern Pharma
LTRN
|
$ 4.07
|
44.4 M
|
$ -18.2 M
|
-2.1
|
∙ |
$ -1.5
|
 |
 |
Gossamer Bio
GOSS
|
$ 0.18
|
41.1 M
|
$ -63 M
|
-0.5
|
1.5
|
$ -0.7
|
 |